3Ulukan H,Swaan PW.Camptothecins:a review of their chemotherapeutic potential.Drug,2000,62(14):2 039
4Padro T,Ruizs,Bieker R,et al.Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia.Blood,2000,95 (8):2 637
5Cortes J,Estey E,Beran M,et al.Cy clophosphamide,ara-C and topotecan (CAT) for patients with refractory or relapsed acute leukemia.Leuk Lymphoma,2000,36(5/6):479
二级参考文献10
1Kantarjian HM,Giles FJ,O Brien SM,et al.Clinical course and therapy of chronic myelogenous leukemia with interferon alpha and chemotherapy [J].Hematol Oncol Clin North Am,1998,12:31- 80.
2Seiter K,Feldman EJ,Halicka HD,et al.Phase I clinical and laboratory evaluation of topotecan and cytarabine in patients with acute leukemia [J].J Clin Oncol,1997,15:44- 51.
3Park SJ,Kim DW,Kim HJ,et al.Topotecan based combination chemotherapy in patients with transformed chronic myelogenous leukemia and advanced myelodysplastic syndrome [J].Korean J Intern Med,2000,15:122- 126.
4Eischen CM,Kottke TJ,Martins LM,et al.Comparison of apoptosis in wild type and Fas resistant cells:chemotherapy induced apoptosis is not dependent on Fas/Fas ligand interactions [J].Blood,1997,90:935- 943.
5Fadok VA,Voelker DR,Campbell PA,et al.Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages [J].J Immunol,1992,148:2207- 2216.
6Koopman G,Reutelingsperger CP,Kuijten GA,et al.Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis [J].Blood,1994,84:1415- 1420.
7Seiter K.Induction of apoptosis by topotecan:implications for the treatment of leukemia [J].Semin Hematol,1998,35(3suppl 4):22- 25.
8Wickremasinghe RG,Hoffbrand AV.Biochemical and genetic control of apoptosis:Relevance to normal hematopoiesis and hematological malignancies [J].Blood,1999,93:3587.
9Hengartner MO.The biochemistry of apoptosis [J].Nature,2000,407:770- 775.
10Wesselborg S,Engels IH,Rossmann E,et al.Anticancer drugs induce caspase 8/FLICE activation and apoptosis in the absence of CD95 receptor/ligand interaction [J].Blood,1999,93:3053-3060.
5Froelich-Ammon SJ, Osheroff N. Topoisomerase poisons: harnessing the dark side of enzyme mechanism [ J ]. J Biol Chem,1995,270(37) :21 429.
6Song Q, Lees-Miller SP, Kumar S, et al. DNA-dependent protein kinase catalytic subunit: a target for an ICE-like protease in apoptosis[ J]. EMBO J, 1996,15(13) :3 238.
7Cohen GM, Sun XM, Fearnhead H, et al. Formation of large molecular weight fragments of DNA is a key committed step of apoptosis in thymocytes[ J]. J Immunol, 199g, 153(2) :507.
8Kluza L, Lansiaux A, Wattez N, et al. Apoptotic response of HL-60 human leukemia cells to the antitumor drug TAS- 103[J]. Cancer Res, 2000,60 (15) :4077.
9Wang JC. DNA topoisomerases[ J ]. Annu Rev Biochem, 1996,65:635.
10Seiter K. Induction of apoptosis by topotecan: implications for the treatment of leukemia [ J ]. Semin Hematol, 1998, 35(3 Suppl g) :22.
